Products
Tilray Brands — Medicinal Cannabis Products in Australia (2026)
Tilray Brands is one of the world's largest cannabis companies, with a significant presence in Australia's medicinal market. A complete guide to Tilray's Australian products, access pathway and patient considerations in 2026.
Tilray Brands (NASDAQ: TLRY) is one of the world’s largest cannabis companies — a Canadian multinational with operations across North America, Europe, Latin America and Australia. In Australia’s medicinal market, Tilray products are available through the TGA prescription pathway and represent one of the most globally experienced cannabis producers accessible to Australian patients.
Company background
Headquarters: Leamington, Ontario, Canada (with global operations)
Stock listing: NASDAQ: TLRY
Key markets: Canada, USA, Germany, UK, Portugal, Australia and others
Australian access: TGA SAS-B prescription framework; imported product range
Tilray was founded in 2013 in Canada and was among the first cannabis companies to receive federal approval for cannabis exports in Canada, allowing it to supply medical markets globally. The company has grown through aggressive acquisitions — including Aphria (2021), HEXO (2023) and other brands — to become one of the highest-volume cannabis producers globally.
In Australia, Tilray products are available as imported pharmaceutical-grade cannabis, meeting TGA import licence and quality requirements.
Tilray’s Australian product range
Tilray distributes multiple cannabis product lines in Australia, reflecting its broad international portfolio. Australian-available products may include:
Dried flower cultivars: Tilray’s cultivars cover indica, sativa and hybrid categories at multiple potency levels. Canadian cultivation expertise produces consistently high-quality flower with verified cannabinoid profiles.
Cannabis oils: THC-dominant, balanced and CBD-dominant oil formulations. Tilray’s oil products benefit from pharmaceutical-grade Canadian extraction and formulation processes.
Specialty formats: Depending on current Australian regulatory approvals, other Tilray formats may be available through registered pharmacies.
Note: Tilray’s specific Australian product range evolves as TGA approvals are obtained and pharmacy partnerships are established. Confirm current product availability with your prescribing pharmacy.
Why Tilray matters in the Australian market
Tilray’s significance in Australia goes beyond its products:
International quality standard: Tilray’s products are produced to Canadian federal pharmaceutical standards — one of the world’s most rigorous cannabis regulatory frameworks. This history of high-standard production benefits Australian patients through product consistency and quality assurance.
Supply certainty: As one of the world’s highest-volume producers, Tilray can maintain supply to the Australian market more reliably than smaller producers facing crop cycle or regulatory disruptions.
Research investment: Tilray has a significant clinical research portfolio, contributing to the global evidence base for medicinal cannabis across multiple conditions.
Cost competitiveness: Tilray’s scale in Canadian production creates unit economics that can translate to competitive pricing in the Australian market.
How to access Tilray products in Australia
Tilray products are accessed through the standard TGA SAS-B prescription pathway:
- Consult with a TGA-authorised prescriber
- Request Tilray products specifically, or discuss your needs and let your prescriber recommend from available options
- Prescription dispensed through registered Australian pharmacies that stock Tilray products
- National delivery
Tilray vs domestic Australian producers
| Consideration | Tilray (imported) | Australian producers (LGP, Cann Group) |
|---|---|---|
| Origin | Canada | Australia |
| Production scale | Very high | Moderate |
| Track record | 10+ years global | ~8 years Australian |
| Carbon footprint | Longer shipping | Lower transport impact |
| Quality standard | Canadian federal standard | TGA Australian standard |
Both imported and domestic products meet TGA Australian standards. The choice between them is ultimately clinical — your prescriber will recommend based on your condition, preferred cannabinoid profile and available product formats.
Frequently asked questions — Tilray in Australia
Are Tilray products available in Australian pharmacies?
Yes — Tilray products are available through the TGA prescription system via registered Australian pharmacies. Confirm specific product availability with your pharmacy as the range evolves.
Is Tilray a Canadian or Australian company?
Tilray is a Canadian company (NASDAQ-listed) with global operations including Australia. Its Australian products are imported from Canadian production facilities under TGA import licence.
Are Tilray products the same as what’s available in Canada?
Similar products may be available, but TGA-registered products go through Australian-specific approval processes. The product names, formulations and concentrations available in Australia may differ from Canadian market offerings.
Is Tilray the same as Aphria?
Tilray acquired Aphria in 2021 in one of the cannabis industry’s largest mergers. Products previously branded under Aphria are now part of the Tilray portfolio.